News from cannabis science, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 31, 2014, 11:07 ET
Jul 30, 2014, 07:30 ET

CBIS Very Excited Over Federal Cannabis Legalization Efforts in U.S. House and Senate to Change Medical Cannabis Laws

Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, is extremely...

Jul 29, 2014, 09:20 ET

Cannabis Science, Inc. (CBIS) Applauds New York Times Editorial Board Stance on 'Repealing Prohibition, Again'; NYT Editorial Is Bell Weather of Change

 Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting,...

Jul 24, 2014, 07:56 ET

Cannabis Science Appoints Dr. Roscoe M. Moore Jr., US Assistant Surgeon General (retired) for a Second Term on the Scientific Advisory Board as Special Senior Advisor to the Company

Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting is pleased...

Jul 18, 2014, 13:40 ET
Jul 08, 2014, 09:41 ET

Cannabis Science, Inc. (CBIS) Prepares for New York State as it becomes the 23rd state to authorize Medical Marijuana use

 Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting applauds...

Jun 05, 2014, 10:44 ET

Cannabis Science, Inc. (CBIS) Reports Strongest Financial Position in its History, Citing Filings & Financial Statements as the Company Moves Forward with Multiple Cannabis Drug Development Programs

Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, issued...

Jun 03, 2014, 12:22 ET

CBIS Reports on CBS News; Historic Marijuana Vote from United States House of Representatives Creates Serious Confidence as Marijuana Wins U.S. House Vote for First Time in History

Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development is pleased to announce a historic...

Jun 02, 2014, 09:15 ET

Cannabis Science Operational Update: First Data from Preclinical Development Expected This Week; Cannabis Science Plans to Open Informational Hotline for General Public

 Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in the development of cannabis based medicine is very pleased to announce that...

May 27, 2014, 14:08 ET

Cannabis Science Cheers Dr. Oz on Becoming a Vocal Supporter of Medical Marijuana on The Larry King Live Show

Cannabis Science, Inc. (OTC-QB: CBIS), a U.S. Company specializing in the development of cannabis based medicine is glad to see a new milestone has...

May 27, 2014, 08:11 ET

Cannabis Science Inc. Moves Forward with MEDIWIET Preparing Observational Study in the Netherlands

Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in the development of cannabis based medicine, is working closely with Mediwiet and...

May 22, 2014, 07:00 ET

Cannabis Science Issues CBN Patent and R&D Progress Guidance for the 2nd Quarter of 2014

Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development issues CBN patent and R&D...

May 01, 2014, 06:09 ET

Cannabis Science Supports Patients Out of Time's Eighth National Clinical Conference on Cannabis Therapeutics held May 8-10, 2014 in Portland, Oregon

 Cannabis Science, Inc. (OTC-QB: CBIS), a U.S. Company specializing in cannabis based drug development and related consulting is proud to...

Apr 30, 2014, 08:12 ET

Cannabis Science Inc. Signs Agreement With MEDIWIET to Conduct Clinical Observational Study in the Netherlands

 Cannabis Science, Inc. (OTCQB: CBIS), a U.S. Company specializing in the development of cannabis based medicines is proud to announce a joint...

Apr 28, 2014, 10:22 ET

Cannabis Science, Inc. (CBIS) Commends Dr. Sanjay Gupta on His On-Going Contribution to Learning and Educating Regarding the Efficacy of Medical Cannabis for Patients In Need

 Cannabis Science, Inc. (CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, commends top...

Apr 04, 2014, 10:20 ET

Cannabis Science Applauds Extending Legalization of Nevada Medical Cannabis Program and Continued Growth of the U.S. Industry; Examines Opportunities Presented by the Opening of the Nevada Market

Cannabis Science, Inc. (OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting is proud to...

Mar 19, 2014, 10:03 ET

Cannabis Science (CBIS) Applauds Unprecedented United States Federal Government Approval of University Study of Medical Cannabis for Veterans Suffering from PTSD

Cannabis Science, Inc. (NASDAQ OTC: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting,...

Mar 12, 2014, 08:29 ET

Cannabis Science (CBIS) Announces Investors In Private Placement Include Weedmaps and Dutch Investment Company; Weedmaps and CBIS to Develop Joint Ventures and Marketing Relationship

 (CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development and related consulting, announces...

Mar 11, 2014, 07:47 ET
Mar 07, 2014, 10:19 ET

Cannabis Science (CBIS) Closes Recently Announced $1 Million PPM Financing To Fund Research and Development In the U.S.A. and Europe; Funding Effort Fully Subscribed

 (CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development and related consulting, closes the...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge